Cochlear Limited (FRA:OC5)

Market Cap	10.15B
Revenue (ttm)	1.31B
Net Income (ttm)	217.10M
Shares Out	n/a
EPS (ttm)	3.31
PE Ratio	46.73
Forward PE	40.31
Dividend	2.46 (1.57%)
Ex-Dividend Date	Sep 18, 2025

Volume	n/a
Average Volume	33
Open	156.42
Previous Close	157.18
Day's Range	156.42 - 156.42
52-Week Range	135.12 - 191.30
Beta	n/a
RSI	49.29
Earnings Date	Feb 13, 2026

About Cochlear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered i...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1981
• Employees: 5,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OC5

Financial Performance

In 2025, Cochlear's revenue was 2.34 billion, an increase of 4.81% compared to the previous year's 2.24 billion. Earnings were 388.90 million, an increase of 9.00%.

Financial numbers in AUD